Anhui Anke Biotechnology (Group) Management
Management criteria checks 2/4
Anhui Anke Biotechnology (Group)'s CEO is Jian Ping Yao, appointed in Dec 2023, has a tenure of 1.08 years. directly owns 0.41% of the company’s shares, worth CN¥54.37M. The average tenure of the management team and the board of directors is 1.1 years and 3.6 years respectively.
Key information
Jian Ping Yao
Chief executive officer
CN¥857.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.4% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price Is Matching Sentiment Around Its Earnings
Sep 25
Anhui Anke Biotechnology (Group) (SZSE:300009) Will Pay A Dividend Of CN¥0.25
May 23Earnings Working Against Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price
Mar 01CEO
Jian Ping Yao (52 yo)
1.1yrs
Tenure
CN¥857,000
Compensation
Mr. Jian Ping Yao is Chief Executive Officer of Anhui Anke Biotechnology (Group) Co., Ltd. from December 12, 2023. He was Senior Vice President of Anhui Anke Biotechnology (Group) Co., Ltd.He was Deputy G...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board of Directors & President | 31.7yrs | CN¥2.71m | 26.63% CN¥ 3.6b | |
| Chief Executive Officer | 1.1yrs | CN¥857.00k | 0.41% CN¥ 54.4m | |
| Financial Director | 1.1yrs | CN¥438.70k | 0.0024% CN¥ 321.9k | |
| Senior Vice President | no data | CN¥1.11m | 0.23% CN¥ 30.9m | |
| Senior VP & Director | no data | CN¥651.00k | 0.61% CN¥ 82.3m | |
| VP & Director | 2.6yrs | CN¥635.00k | 0.13% CN¥ 17.7m | |
| Vice President | 1.8yrs | CN¥531.00k | 0.048% CN¥ 6.5m | |
| Vice President | 1.1yrs | CN¥1.10m | 0.025% CN¥ 3.3m | |
| Vice President | 2.1yrs | CN¥687.00k | 0.024% CN¥ 3.2m | |
| Vice President | 1.1yrs | CN¥887.00k | 0.0088% CN¥ 1.2m | |
| Secretary of the Board & Director | 5.1yrs | CN¥469.00k | 0.022% CN¥ 3.0m | |
| Vice President | 1.1yrs | CN¥506.00k | 0.020% CN¥ 2.7m |
1.1yrs
Average Tenure
49.5yo
Average Age
Experienced Management: 300009's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board of Directors & President | 31.7yrs | CN¥2.71m | 26.63% CN¥ 3.6b | |
| Senior VP & Director | 17.8yrs | CN¥651.00k | 0.61% CN¥ 82.3m | |
| VP & Director | 2.1yrs | CN¥635.00k | 0.13% CN¥ 17.7m | |
| Secretary of the Board & Director | 2.1yrs | CN¥469.00k | 0.022% CN¥ 3.0m | |
| Director | less than a year | CN¥72.00k | 0.039% CN¥ 5.3m | |
| Vice Chairman of the Board | 21.4yrs | CN¥976.00k | 6.89% CN¥ 923.7m | |
| Director | 11.2yrs | CN¥501.00k | 0.072% CN¥ 9.7m | |
| Independent Director | 5.1yrs | CN¥75.00k | no data | |
| Independence Director | 5.1yrs | CN¥75.00k | no data | |
| Director | 2.1yrs | CN¥501.50k | 0.059% CN¥ 7.9m | |
| Independent Director | 2.1yrs | CN¥75.00k | no data | |
| Independent Director | 2.1yrs | CN¥75.00k | no data |
3.6yrs
Average Tenure
59yo
Average Age
Experienced Board: 300009's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 13:33 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Anhui Anke Biotechnology (Group) Co., Ltd. is covered by 15 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Pei Hui Tang | Chasing Securities |
| Pei Cheng | China Galaxy Securities Co., Ltd. |